Status:
UNKNOWN
Registry for Pulmonary Hypertension in China
Lead Sponsor:
Chinese Academy of Medical Sciences, Fuwai Hospital
Conditions:
Pulmonary Arterial Hypertension
Chronic Thromboembolic Pulmonary Hypertension
Eligibility:
All Genders
Brief Summary
1. To characterize the demographics and clinical course of the patient population diagnosed as having WHO group I pulmonary arterial hypertension and WHO group IV pulmonary hypertension due to chronic...
Detailed Description
Data describing the natural history of idiopathic and familial pulmonary arterial hypertension were derived from a registry conducted at our institution prior to 2006. Since then, targeted therapies f...
Eligibility Criteria
Inclusion
- Signed patients'consent
- Diagnosed by right heart catheterization one month within study enrollment
- patients who were firstly diagnosed as pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension
Exclusion
- Not meeting inclusion criteria
Key Trial Info
Start Date :
August 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
3079 Patients enrolled
Trial Details
Trial ID
NCT01417338
Start Date
August 1 2009
End Date
December 1 2020
Last Update
June 9 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fu Wai Hospital
Beijing, China, 100037